Parrella Health Law
By Christopher A. Parrella, Esq., CPC, CHC, CPCO
Boston, MA
A Health Care Provider Defense and Compliance Firm

The FDA’s February 2026 guidance on cybersecurity in medical devices is directed primarily at manufacturers and premarket submissions. But healthcare providers should not ignore it. The guidance makes one point unmistakably clear: cybersecurity is now part of medical device safety. That matters for hospitals, behavioral health providers, SUD treatment centers, outpatient mental health practices, ambulatory programs, and any provider organization that relies on connected medical devices, software platforms, remote monitoring tools, cloud-based systems, or vendor-managed technology.

FDA is not treating cybersecurity as a back-office IT issue. FDA is treating it as a patient safety issue.

What the FDA Guidance Says

The guidance applies to devices with cybersecurity considerations, including devices with software, firmware, programmable logic, network capability, internet connectivity, cloud connections, wireless communication, USB access, or other electronic interfaces.

FDA expects manufacturers to address cybersecurity throughout the device lifecycle, not only at the time of product launch. The guidance emphasizes:

• Secure product development;
• Threat modeling;
• Cybersecurity risk assessments;
• Software bills of materials;
• Security architecture documentation;
• Cybersecurity testing;
• Patchability and updatability;
• Vulnerability monitoring;
• Cybersecurity labeling and user instructions;
• Postmarket cybersecurity management plans.

The core message is simple: a device must be designed, maintained, updated, and supported in a way that provides reasonable assurance of safety and effectiveness.

Why This Matters to Providers

Although the guidance is aimed at manufacturers, providers are part of the real-world environment in which these devices operate. FDA expressly recognizes that medical device cybersecurity is a shared responsibility among manufacturers, healthcare facilities, patients, healthcare providers, and other users. That shared responsibility matters because a device may be safe in theory but unsafe in practice if the provider’s network, configuration, vendor management, update process, or user controls are weak.

For providers, the risk is not limited to a data breach. A cybersecurity failure can disrupt patient care, delay treatment, interfere with clinical decision-making, disable equipment, compromise monitoring, or create patient safety exposure. In other words, device cybersecurity is not only a HIPAA issue. It can become a quality-of-care issue, a licensing issue, a payer audit issue, a malpractice issue, and a regulatory compliance issue.

The Provider Compliance Gap

Many provider organizations assume that if a device or platform is FDA-cleared, vendor-supplied, or cloud-hosted, the cybersecurity burden belongs to someone else. That assumption is risky.

Providers still need to understand how the device is deployed, how it connects to the provider’s systems, how updates are installed, how access is controlled, how logs are maintained, how vulnerabilities are communicated, and what happens when the vendor stops supporting the software or device. This is especially important for providers using remote care platforms, patient monitoring tools, medication management systems, EHR-integrated applications, lab interfaces, telehealth tools, and behavioral health technology platforms.

If the provider cannot explain who is responsible for maintaining the device’s cybersecurity posture, the compliance structure is incomplete.

Vendor Contracts Need to Catch Up

The FDA guidance also has practical implications for vendor contracting. Providers should not accept vague cybersecurity language in device, software, or platform agreements. Contracts should address:

• Security updates and patch timelines;
• Vulnerability notification duties;
• Software bill of materials availability, where appropriate;
• End-of-support and end-of-life notices;
• Incident reporting obligations;
• Access control requirements;
• Audit rights;
• Business associate obligations, if PHI is involved;
• Data retention and decommissioning;
• Responsibility for downtime, interruption, and patient safety impacts.

The provider should also know whether the vendor can support the product throughout its expected operational life. A device that cannot be securely patched or supported may become a compliance risk even if it continues to function clinically.

Provider Call to Action

Healthcare providers should inventory connected medical devices, software-enabled clinical tools, and vendor-managed platforms now. Behavioral health, SUD, outpatient mental health, ABA, and other healthcare providers should pay particular attention to technology that affects admission workflows, patient monitoring, medication management, clinical documentation, telehealth delivery, testing, or treatment decisions. The practical next step is not to rewrite the entire compliance program. The first step is to identify which devices and platforms create patient safety, privacy, payer, or operational risk if they are compromised or unsupported.

Providers should then review vendor contracts, update policies, confirm patch and vulnerability procedures, and document who is responsible for maintaining cybersecurity controls.

Parrella Health Law assists healthcare providers in evaluating these risks from the provider side, including vendor contracting, compliance program updates, payer audit readiness, and regulatory risk mitigation. If you have any questions or would like to discuss how this issue may affect your organization, please email Chris directly at cparrella@parrellahealthlaw.com.

Bottom Line

FDA’s 2026 guidance confirms that medical device cybersecurity is now inseparable from patient safety. Manufacturers have the primary premarket burden, but providers cannot treat cybersecurity as solely a vendor problem. If a connected device or clinical platform fails because of a preventable cybersecurity weakness, the provider may still be left answering to patients, regulators, payers, and counsel. For providers, the safest approach is to know what technology is connected, who supports it, how it is updated, and what happens when something goes wrong.